Clinical Ink’s COO & Chief Data Officer, Jonathan Andrus, Awarded SCDM Lifetime Achievement Award

Clinical Ink is excited to recognize its COO & Chief Data Officer, Jonathan Andrus, for being awarded the SCDM Lifetime Achievement Award at the September 2018 SCDM Annual Conference. The Society for Clinical Data Management (SCDM) honored Jonathan for his contributions over the past twenty years, including his past role as SCDM Chair, and present roles as Treasurer and Member of the Board of Trustees. The society is recognized as the world’s largest clinical data management professional organization.Jonathan has been deeply involved with the SCDM organization since 1998. He ran for and was elected to the Board in 2004 and has served in a variety of capacities over the past 14 years, including as Vice Chair, Chair and Treasurer. Most recently, he was appointed for another three-year term, stating, “I’m looking forward to the continued growth and expansion of the society, which will ensure the continued education and advancement of the data management profession.”

Passionate about data management, Jonathan has helped grow the professional society on a global scale, including playing a major role in moving its headquarters from the US to Europe. Further, he has been instrumental in working with the society’s European, Indian, Chinese and Japanese members, supporting and growing activities in these regions with the aim of globally advancing data management.

At Clinical Ink, Jonathan focuses his initiatives on providing customers with the most compliant, efficient and quality-oriented products and services, stating, “Customer satisfaction is my number one priority and our entire company is united under the mission of providing our customers with the best possible experience by delivering a modern approach to clinical trial execution and data management.”

Congratulations to Jonathan for this tremendous recognition. Clinical Ink and the clinical trial data management industry are appreciative of your contributions to advancing clinical trial execution.

About Clinical Ink

Clinical Ink is a global clinical trial technology company that is transforming the clinical trial experience. Founded in 2007, the Company’s proven and future-built CAPTURE platform, which includes solutions for EDC replacement, eCOA, ePRO and more, accelerates time to value while delivering scientific results that matter. With offices in Winston-Salem, NC, and Philadelphia, PA, Clinical Ink is advancing the business model responsible for bringing new treatments to market. Visit clinicalink.com.

Media Contact: Jessica Romero | 336.728.6541 | jessica.romero@clinicalink.com

Scroll to Top